August 19, 2019
ICER’s Final Report on Value of DMD Treatments Leaves Patients Unsatisfied
Read More
August 2, 2019
It’s a Low-Down Dirty Shame
Read More
July 25, 2019
Bipartisan Legislation Seeks to Save Government $100 Billion in Drug Costs
Read More
June 14, 2019
Bluebird Bio Prices TDT Gene Therapy at $1.8 Million
Read More
June 11, 2019
Jacobus Prices LEMS Treatment at Less Than Half of Catalyst’s Similar Drug
Read More
May 24, 2019
FDA Approves Gene Therapy Zolgensma for SMA; Novartis Sets Price at $2.1 Million
Read More
April 16, 2019
NICE Gives Akcea Nod for Tegsedi to Treat Ultra-Rare hAATR
Read More
April 4, 2019
ICER Calls Spinraza Too Pricey, Urges Fair Pricing of Zolgensma
Read More
March 21, 2019
Medicare Part D Spending on Specialty Drugs Climbs to $32.8B in 2015
Read More
Load More
X